Massive transfusion and massive transfusion protocol

Indian Journal of Anaesthesia

Volumn 58, Issue 5, 2014, Pages 590-595

  Patil, Vijaya ^a   Shetmahajan, Madhavi ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Blood loss management; Massive blood transfusion; Massive transfusion protocol

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; FRESH FROZEN PLASMA; PROTHROMBIN;

ACIDOSIS; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD COMPONENT; BLOOD STORAGE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CITRATE TOXICITY; CLINICAL PROTOCOL; DRUG TOXICITY; HEMORRHAGIC SHOCK; HUMAN; HYPERKALEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOTHERMIA; PATIENT MONITORING; RESUSCITATION; REVIEW; TREATMENT OUTCOME;

EID: 84924972675     PISSN: 00195049     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5049.144662     Document Type: Review

References (37)

1. Turan A, Yang D, Bonilla A, Shiba A, Sessler DI, Saager L, et al. Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery. Can J Anaesth 2013;60:761-70.
2. Dutton RP, Lee LA, Stephens LS, Posner KL, Davies JM, Domino KB. Massive hemorrhage: A report from the anesthesia closed claims project. Anesthesiology 2014;121:450-8.
3. Raymer JM, Flynn LM, Martin RF. Massive transfusion of blood in the surgical patient. Surg Clin North Am 2012;92:221-34, vii.
4. Chidester SJ, Williams N, Wang W, Groner JI. A pediatric massive transfusion protocol. J Trauma Acute Care Surg 2012;73:1273-7.
5. Massive transfusion protocol (MTP) for hemorrhagic shock. ASA committee on blood management. Available from: https:// www.asahq.org/For-Members/About-ASA/ASA-Committees/ Committee-on-Blood-Management.aspx [Last accessed on 2014 Sep 27].
6. Diab YA, Wong EC, Luban NL. Massive transfusion in children and neonates. Br J Haematol 2013;161:15-26.
7. th ed. Philadelphia: Churchill Livingstone; 2009. p. 1739-66.
8. Levi M, Jonge Ed. Clinical relevance of the effects of plasma expanders on coagulation. Semin Thromb Hemost 2007;33:810-5.
9. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995;81:360-5.
10. Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010;113:1205-19.
11. Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, et al. Early coagulopathy in multiple injury: An analysis from the German Trauma Registry on 8724 patients. Injury 2007;38:298-304.
12. Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, et al. Early coagulopathy in trauma patients: An on-scene and hospital admission study. Injury 2012;43:26-32.
13. Muriithi EW, Belcher PR, Day SP, Menys VC, Wheatley DJ. Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg 2000;69:1827-32.
14. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: A review. Intensive Care Med 2004;30:1873-81.
15. Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009;116:1097-102.
16. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 2012;109:851-63.
17. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. Management of bleeding following major trauma: An updated European guideline. Crit Care 2010;14:R52.
18. Kashuk JL, Moore EE, Johnson JL, Haenel J, Wilson M, Moore JB, et al. Postinjury life threatening coagulopathy: Is 1:1 fresh frozen plasma: Packed red blood cells the answer? J Trauma 2008;65:261-70.
19. Riskin DJ, Tsai TC, Riskin L, Hernandez-Boussard T, Purtill M, Maggio PM, et al. Massive transfusion protocols: The role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009;209:198-205.
20. Snyder CW, Weinberg JA, McGwin G Jr, Melton SM, George RL, Reiff DA, et al. The relationship of blood product ratio to mortality: Survival benefit or survival bias? J Trauma 2009;66:358-62.
21. Nunez TC, Young PP, Holcomb JB, Cotton BA. Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma 2010;68:1498-505.
22. O'Keeffe T, Refaai M, Tchorz K, Forestner JE, Sarode R. A massive transfusion protocol to decrease blood component use and costs. Arch Surg 2008;143:686-90.
23. Neal MD, Marsh A, Marino R, Kautza B, Raval JS, Forsythe RM, et al. Massive transfusion: An evidence-based review of recent developments. Arch Surg 2012;147:563-71.
24. McCormack PL. Tranexamic acid: A review of its use in the treatment of hyperfibrinolysis. Drugs 2012;72:585-617.
25. CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011;377:1096-101, 1101.e1.
26. Roberts I, Shakur H, Ker K, Coats T, CRASH-2 Trial collaborators. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev 2011:CD004896.
27. Esper SA, Waters JH. Intra-operative cell salvage: A fresh look at the indications and contraindications. Blood Transfus 2011;9:139-47.
28. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: A comparative review. Crit Care Med 2001;29:1261-7.
29. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006;102:998-1006.
30. Fenger-Eriksen C, Anker-Moller E, Heslop J, Ingerslev J, Sørensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: Improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005;94:324-9.
31. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003;31:2450-5.
32. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest 2010;137:209-20.
33. Aboudara MC, Hurst FP, Abbott KC, Perkins RM. Hyperkalemia after packed red blood cell transfusion in trauma patients. J Trauma 2008;64:S86-91.
34. Watts DD, Trask A, Soeken K, Perdue P, Dols S, Kaufmann C. Hypothermic coagulopathy in trauma: Effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998;44:846-54.
35. Ganter MT, Pittet JF. New insights into acute coagulopathy in trauma patients. Best Pract Res Clin Anaesthesiol 2010;24:15-25.
36. rd, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003;55:886-91.
37. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11.